Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant
Brenda M. Sandmaier; Samer Khaled; Betül Oran; Guy Gammon; Denise Trone; Olga Frankfurt
Author Information: Fred Hutchinson Cancer Research Center
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.